Shares of Jean Coutu Group PJC Inc (TSE:PJC.A) have earned an average recommendation of “Hold” from the eight analysts that are covering the firm. One equities research analyst has rated the stock with a sell recommendation and five have assigned a hold recommendation to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is C$19.31.
A number of equities analysts recently issued reports on PJC.A shares. Dundee Securities restated a “neutral” rating and issued a C$20.00 target price on shares of Jean Coutu Group PJC in a research note on Thursday, September 22nd. Royal Bank Of Canada increased their price target on Jean Coutu Group PJC from C$19.00 to C$20.00 and gave the stock a “sector perform” rating in a research report on Wednesday, September 28th. Scotiabank reaffirmed a “sector perform” rating and set a C$19.00 price target on shares of Jean Coutu Group PJC in a research report on Tuesday, July 5th. CIBC reaffirmed a “sector perform” rating and set a C$19.00 price target on shares of Jean Coutu Group PJC in a research report on Wednesday, July 6th. Finally, TD Securities reaffirmed a “reduce” rating and set a C$17.50 price target on shares of Jean Coutu Group PJC in a research report on Wednesday, July 6th.
Jean Coutu Group PJC Company Profile
The Jean Coutu Group (PJC) Inc is a Canada-based company, which is engaged in franchising pharmacy chains. The Company operates through two segments: franchising and generic drugs. Within the franchising segment, the Company carries on the franchising activity under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute; operates approximately two distribution centers, and coordinates various other services for its franchisees.
Receive News & Ratings for Jean Coutu Group PJC Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jean Coutu Group PJC Inc and related companies with MarketBeat.com's FREE daily email newsletter.